AN ALGORITHM FOR CLINICAL AND HEMOSTASIOLOGICAL INVESTIGATION IN OBSTETRIC AND GYNECOLOGICAL CARE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The most common and severe complications during pregnancy, labor, and postpartum period are caused by changes in the hemostatic system: recurrent miscarriage, early-onset severe preeclampsia, placental abruption, placental insufficiency, and thromboembolic events. In gynecological practice, the hemostatic system should be studied before and during hormonal contraception, hormone replacement therapy, during tumor processes, and in the perioperative period. As of now, the range of hemostasiological studies is wide, but the expediency and interpretation of the findings frequently present problems for obstetricians and gynecologists. Due to the above fact, an algorithm that can optimize hemostasiological examination and adequate correction of found disorders has been elaborated.

全文:

受限制的访问

作者简介

P. KIRYUSHCHENKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: masha-kirmail@mail.ru
Moscow,Russia

R. SHMAKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: mdshmakov@mail.ru
Moscow,Russia

E. ANDAMOVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: elena_doctor@mail.ru
Moscow,Russia

M. TAMBOVTSEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tambovtsevamr@mail.ru
Moscow,Russia

参考

  1. Долгов В.В., Свирин П.В. Лабораторная диагностика нарушений гемостаза. М.; Тверь: Триада-X; 2005. 227 с.
  2. Дементьева И. И., Чарная М. А., Морозов Ю. А. Патология системы гемостаза: Руководство для врачей. М.: ГЭОТАР-Медиа; 2011. 283 с.
  3. Bloemenkamp K.W., Rosendaal F.R., Helmerhorst F.M., Vandenbroucke J.P. Higher risk of venous thrombosis during early use of oral contraceptives in women with hereditary clotting defects. Arch. Intern. Med. 2000; 160(1): 49—52.
  4. James A.H., Tapson V.F., Goldhaber S.Z. Thrombosis during pregnancy and the postpartum period. Am. J. Obstet. Gynecol. 2005; 193(1): 216—9.
  5. Folkeringa N., Brouwer J.L.P., Korteweg F., Veeger N.J., Erwich J.J., van der Meer J. High risk of pregnancy-related venous thromboembolism in women with multiple thrombo-philic defects. Br. J. Haematol. 2007; 138(1): 110—6.
  6. Ray J.G., Chan W.S. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet. Gynecol. Surv. 1999; 54(4): 265—71.
  7. Sanson B.J., Simioni P., Tormene D., Moia M., Friederich P. W., Huisman M. V. et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood. 1999; 94(11): 3702—6.
  8. Зайнулина М.С., Корнюшина Е.А., Бикмуллина Д.Р. Тромбофилия: этиологический фактор или патогенетический аспект осложненного течения беременности? Журнал акушерства и женских болезней. 2010; 1: 18—30.
  9. Ginsberg J.S., Greer I., Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001; 119(1): 122—31.
  10. Баркаган З.С., Момот А.П. Диагностика и контролируемая терапия нарушений гемостаза. М.: Ньюдиамед; 2001. 296 с.
  11. Lee C.A., Chi C., Pavord S.R., Bolton-Maggs P.H., Pollard D., Hinchcliffe-Wood A. et al. The obstetric and gynaecological management of women with inherited bleeding disordersreview with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization. Haemophilia. 2006; 12(4): 301-36.
  12. Момот А.П., Елыкомов В.А., Баркаган З.С. Методика и клиническое значение паракоагуляционного фенант-ролинового теста. Клиническая лабораторная диагностика. 1996; 4: 17-20.
  13. Папаян Л.П., Князева Е.С. Д-димер в клинической практике: Пособие для врачей. М.: Инсайт полиграфик; 2002. 20 с.
  14. Алексеева Л.А., Рагимов А.А. ДВС-синдром: Руководство. М.: ГЭОТАР-Медиа; 2010. 120 с.
  15. Сидельникова В.М., Кирющенков П.А. Гемостаз и беременность. М.: Триада-Х; 2004. 208 с.
  16. Baglin T., Barrowcliffe T.W., Coben A. Guidelines on the use and monitoring of heparin British Committee for Standards in haematology. Br. J. Haematol. 2006; 133(1): 19-34.
  17. Laposata M., Green D., Van Cott E.M., Barrowcliffe T.W., Goodnight S.H., Sosolik R.C. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch. Pathol. Lab. Med. 1998; 122(9): 799-807.
  18. Макацария А.Д., ред. Тромбогеморрагические осложнения в акушерско-гинекологической практике. М.: МИА; 2011. 1050 с.
  19. Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3): 311-37.
  20. Заболотских И.Б., Синьков С.В., Шапошников С.А. Диагностика и коррекция расстройств системы гемостаза. М.: Практическая медицина; 2008. 333 с.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013
##common.cookie##